Ajanta Pharma Ltd AJANTPHARM Financial and Strategic SWOT Analysis Review [Report Updated: 29082018] Prices from USD $125

11:41 EDT 13 Oct 2018 | BioPortfolio Reports

Ajanta Pharma Ltd AJANTPHARM Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Ajanta Pharma Ltd Ajanta Pharma is a specialty pharmaceutical company, which focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has a presence in cardiology, pain management, dermatology and ophthalmology therapy areas. It provides generics in developed markets of USA and branded generics in emerging countries such as India, Africa, CIS, Middle East and South East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and antimalarial products to Africa and Global Fund. It operates subsidiaries in Mauritius, Philippines, Nigeria, the US and the UK. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.

Ajanta Pharma Ltd Key Recent Developments

Jul 31,2018: Ajanta Pharma reports Q1 FY 2019 consolidated result

Jul 27,2018: Ajanta Pharma: Update on US FDA inspection

Jul 13,2018: National drug regulator finds illegal manufacturing at Pondy firm

May 02,2018: Ajanta Pharma reports Q4 FY 2018 Consolidated Result

Jan 25,2018: Ajanta Pharma: Q3 Income from Operations at Rs. 587 cr., PAT at Rs. 147 cr.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Ajanta Pharma Ltd AJANTPHARM Financial and Strategic SWOT Analysis Review [Report Updated: 29082018] Prices from USD $125


More From BioPortfolio on "Ajanta Pharma Ltd AJANTPHARM Financial and Strategic SWOT Analysis Review [Report Updated: 29082018] Prices from USD $125"

Quick Search


Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...